Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | TSHR | P16473 | 4/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CETP | P11597 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8210492 | 0.98 | ALDH1A1 (0.61) | ALDH1A1TSHRMAPK1TDP1L3MBTL1 | |
| SCHEMBL27430111 | 0.98 | ALDH1A1 (0.61) | ALDH1A1TSHRMAPK1TDP1L3MBTL1 | |
| SCHEMBL1840794 | 0.98 | ALDH1A1 (0.61) | ALDH1A1TSHRMAPK1TDP1L3MBTL1 | |
| SCHEMBL5681521 | 0.98 | ALDH1A1 (0.61) | ALDH1A1TSHRMAPK1TDP1L3MBTL1 | |
| SCHEMBL1836597 | 0.98 | ALDH1A1 (0.61) | ALDH1A1TSHRMAPK1TDP1L3MBTL1 | |
| SCHEMBL1841908 | 0.98 | ALDH1A1 (0.61) | ALDH1A1TSHRMAPK1TDP1L3MBTL1 | |
| Formaldehyde SCHEMBL28519442 | 0.97 | ALDH1A1 (0.60) | ALDH1A1TSHRMAPK1TDP1L3MBTL1 | |
| Formaldehyde SCHEMBL28519397 | 0.95 | ALDH1A1 (0.58) | ALDH1A1TSHRMAPK1TDP1L3MBTL1 | |
| Formaldehyde SCHEMBL28521535 | 0.95 | ALDH1A1 (0.58) | ALDH1A1TSHRMAPK1TDP1L3MBTL1 | |
| SCHEMBL1836932 | 0.95 | ALDH1A1 (0.69) | ALDH1A1TSHRMAPK1TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008013427-A1 | ORGANIC TFTS AND METHOD FOR FABRICATING THE SAME | LG CHEM, LTD. (KR) | 2008-01-31 | — | — | WO | claimed |
| EP-3838892-B1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2022-10-12 | — | — | EP | disclosed |
| EP-3293173-B1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2021-07-28 | — | — | EP | disclosed |
| EP-3838892-A1 | METHOD FOR PRODUCING ISOCYANATE | Asahi Kasei Kabushiki Kaisha (JP) | 2021-06-23 | — | — | EP | disclosed |
| EP-2980066-B1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2021-04-21 | — | — | EP | disclosed |
| EP-3096369-B1 | ORGANIC SOLAR CELL AND METHOD FOR MANUFACTURING SAME | LG CHEMICAL LTD (KR) | 2020-10-14 | — | — | EP | disclosed |
| EP-3153499-B1 | METHOD FOR PRODUCING N-SUBSTITUTED CARBAMIC ACID ESTER | ASAHI CHEMICAL IND (JP) | 2018-09-19 | — | — | EP | disclosed |
| US-20180179499-A1 | BIOBASED PRODUCTION OF FUNCTIONALIZED ALPHA-SUBSTITUTED ACRYLATES AND C4-DICARBOXYLATES | LCY BIOSCIENCES INC. (CA) | 2018-06-28 | — | — | US | disclosed |
| EP-3303375-A1 | BIOBASED PRODUCTION OF FUNCTIONALIZED ALPHA-SUBSTITUTED ACRYLATES AND C4-DICARBOXYLATES | BioAmber Inc. (US) | 2018-04-11 | — | — | EP | disclosed |
| EP-3293173-A1 | METHOD FOR PRODUCING ISOCYANATE | Asahi Kasei Kabushiki Kaisha (JP) | 2018-03-14 | — | — | EP | disclosed |
| CN-1229382-C | Semi-synthetic process and intermediates thereof | PHARMA MAR SA (ES) | 2005-11-30 | — | — | CN | disclosed |
| EP-1287004-B1 | SYNTHETIC PROCESS FOR THE MANUFACTURE OF AN ECTEINASCIDIN COMPOUND | PHARMA MAR SA (ES) | 2005-07-27 | — | — | EP | disclosed |
| CN-1211386-C | Antitumoral analogue of Et-743 | PHARMA MAR SA (ES) | 2005-07-20 | — | — | CN | disclosed |
| EP-1280809-B1 | ANTITUMORAL ECTEINASCIDIN DERIVATIVES | PHARMA MAR SA (ES) | 2005-07-06 | — | — | EP | disclosed |
| EP-1496060-A1 | Antitumoral analogs of ET-743 | PHARMA MAR, S.A. (ES) | 2005-01-12 | — | — | EP | disclosed |
| EP-1185536-B1 | HEMISYNTHETIC METHOD AND INTERMEDIATES THEREOF | PHARMA MAR SA (ES) | 2004-11-24 | — | — | EP | disclosed |
| EP-1289999-B1 | ANTITUMORAL ANALOGS OF ET-743 | PHARMA MAR SA (ES) | 2004-11-17 | — | — | EP | disclosed |
| CN-1440414-A | synthetic method for producing ecteinascidin compounds | PHARMA MAR SA (ES) | 2003-09-03 | — | — | CN | disclosed |
| CN-1360588-A | Hemisynthetic method and intermediate thereof | PHARMA MAR SA (ES) | 2002-07-24 | — | — | CN | disclosed |
| US-6342349-B1 | A SOLID SUPPORT SUBSTRATE CONTAINING A CLEAVABLE SIGNAL ELEMENT, A SIGNAL RESPONSIVE MOIETY AND A CLEAVABLE SPACER; ANALYTES BIND THE SIGNAL ELEMENT, ANCHORING THE RESPONSIVE MOIETY TO THE ELEMENT SUBSTRATE-ATTACHING END AFTER CLEAVAGE | BURSTEIN TECHNOLOGIES, INC. | 2002-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180179499-A1 | BIOBASED PRODUCTION OF FUNCTIONALIZED ALPHA-SUBSTITUTED ACRYLATES AND C4-DICARBOXYLATES | COASY, ADSL, ALAD | ALDH1A1 157/4885TSHR 3786/4885MAPK1 3810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.